GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » 5-Year Yield-on-Cost %

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) 5-Year Yield-on-Cost % : 1.59 (As of Apr. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings 5-Year Yield-on-Cost %?

Aspen Pharmacare Holdings's yield on cost for the quarter that ended in Dec. 2023 was 1.59.


The historical rank and industry rank for Aspen Pharmacare Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:

APNHY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.36   Med: 0.87   Max: 4.54
Current: 1.59


During the past 13 years, Aspen Pharmacare Holdings's highest Yield on Cost was 4.54. The lowest was 0.36. And the median was 0.87.


APNHY's 5-Year Yield-on-Cost % is ranked worse than
62.32% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs APNHY: 1.59

Competitive Comparison of Aspen Pharmacare Holdings's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's 5-Year Yield-on-Cost % falls into.



Aspen Pharmacare Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Aspen Pharmacare Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Aspen Pharmacare Holdings  (OTCPK:APNHY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Aspen Pharmacare Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019